TMDX 89.11 (+3.64%)
US89377M1099Medical Devices & InstrumentsMedical Devices

TransMedics Group (TMDX) Financial Metrics

This table shows a selected set of financial data points of TransMedics Group (TMDX). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -0.77 0 -102.55 2.57B -0.05 241.62M -192.09M -8M -25.03M 394.81M
2022 -1.23 0 -50.35 1.82B -0.18 93.46M -57.72M -27.06M -36.23M 201.18M
2021 -1.6 0 -11.97 529.14M -0.31 30.26M -32.38M -38.49M -44.22M 25.58M
2020 -1.16 0 -17.1 491.59M -0.22 25.64M -30.72M -23.15M -28.75M 24.58M
2019 -2.36 0 -8.05 270.03M -0.46 23.6M -32.45M -28.81M -33.55M 20.09M
2018 -1.64 0 0 0 -0.6 13.02M -26.4M -20.23M -23.76M 20.24M
2017 -1.44 0 0 0 -0.44 7.69M -23.36M -19.09M -20.82M 11.94M
2016 -1.66 0 0 0 -0.66 6.21M -25.59M -22.66M -24.07M 9.84M
2006 0 0 0 0 0 0 0 0 -17.55M 9.01M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.